New Frontiers for Cardiac Risk Assessment: C-Reactive Protein
Current theories of atherosclerotic plaque formation suggest that inflammation plays a key role in coronary heart disease. In an effort to augment current tools for cardiac risk assessment, researchers have found that levels of the inflammatory marker C-reactive protein (CRP) may play an important role in gauging an individual's risk for a cardiac event. While not currently recommended for mass population screening, measurement of CRP may play an increasing part in identifying at-risk patients and guiding pharmacologic intervention.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
Document Type: Research Article
Publication date: 2006-03-01
More about this publication?
- The Consultant Pharmacist® is the official peer-reviewed journal of the American Society of Consultant Pharmacists. It is dedicated exclusively to the medication needs of the elderly in all settings, including adult day care, ambulatory care, assisted living, community, hospice, and nursing facilities. This award-winning journal is a member benefit of ASCP. Individuals who are not members and wish to receive The Consultant Pharmacist® will want to consider joining ASCP.
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Membership Information
- Information for Advertisers
- Ingenta Connect is not responsible for the content or availability of external websites